BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Torre-Muruzabal T, Devoght J, Van den Haute C, Brône B, Van der Perren A, Baekelandt V. Chronic nigral neuromodulation aggravates behavioral deficits and synaptic changes in an α-synuclein based rat model for Parkinson's disease. Acta Neuropathol Commun 2019;7:160. [PMID: 31640762 DOI: 10.1186/s40478-019-0814-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Helwig M, Ulusoy A, Rollar A, O'Sullivan SA, Lee SSL, Aboutalebi H, Pinto-Costa R, Jevans B, Klinkenberg M, Di Monte DA. Neuronal hyperactivity-induced oxidant stress promotes in vivo α-synuclein brain spreading. Sci Adv 2022;8:eabn0356. [PMID: 36044566 DOI: 10.1126/sciadv.abn0356] [Reference Citation Analysis]
2 Claes M, De Groef L, Moons L. The DREADDful Hurdles and Opportunities of the Chronic Chemogenetic Toolbox. Cells 2022;11:1110. [DOI: 10.3390/cells11071110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Vucic S, Pavey N, Haidar M, Turner BJ, Kiernan MC. Cortical hyperexcitability: Diagnostic and pathogenic biomarker of ALS. Neurosci Lett 2021;759:136039. [PMID: 34118310 DOI: 10.1016/j.neulet.2021.136039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Tran FH, Spears SL, Ahn KJ, Eisch AJ, Yun S. Does chronic systemic injection of the DREADD agonists clozapine-N-oxide or Compound 21 change behavior relevant to locomotion, exploration, anxiety, and depression in male non-DREADD-expressing mice? Neurosci Lett 2020;739:135432. [PMID: 33080350 DOI: 10.1016/j.neulet.2020.135432] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]